NCT04572893: A trial that was reported late by Bristol-Myers Squibb
This trial has reported, although it was 26 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04572893 |
|---|---|
| Title | An Open-Label, Exploratory Study of the Safety and Preliminary Efficacy of Danicamtiv in Stable Ambulatory Participants With Primary Dilated Cardiomyopathy Due to Either MYH7 or TTN Variants or Other Causalities |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 4, 2020 |
| Completion date | Feb. 22, 2024 |
| Required reporting date | Feb. 21, 2025, midnight |
| Actual reporting date | March 20, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 26 |